Press Releases

uMotif expands leadership team to support growth in US and EU markets

uMotif expands leadership team to support growth in US and EU markets LONDON and BOSTON, 19 July 2022 -- uMotif, creators of the patient-first eCOA / ePRO and engagement platform transforming the reliability of patient-reported and site-based endpoint data has appointed three new executive leaders. The expanded leadership team will drive uMotif’s ambitious growth strategy in the US and European markets, including guiding future development and adoption of uMotif’s intuitive, retention-boosting technology.

MicrobioSeq Supercharges Microbial Research by Bacterial Whole Genome De Novo Sequencing

CD Genomics MicrobioSeq has launched the Bacterial Whole Genome De Novo Sequencing to help scientific researchers better understand bacterial biodiversity, physiology, metabolism and function.

CD Genomics Unveils Chloroplast DNA (cpDNA) Sequencing Service for Your Biological Research

Chloroplast DNA (cpDNA) plays an important role in revealing the origin of species, biological evolution, and kinship between different species. CD Genomics is pleased to offer the Chloroplast DNA (cpDNA) Sequencing service that has important applications in evolutionary biology research and forensic science.

Celegence acquires Qdossier to bolster its regulatory consultancy services and solutions for the pharmaceutical industry

Celegence acquires Qdossier to extend network of regulatory affairs services consultants and solutions for the pharmaceutical industry

Signant Strengthens Digitally Optimized Trial Strategy with Delivery of Study Supplies Direct to Patients’ Homes

Signant Health, the leader in evidence generation for modern clinical trials, announced today enhancements to its Randomization and Trial Supply Management (RTSM) platform to enable direct-to-patient clinical supply distribution. With Signant SmartSignals RTSM, customers can leverage additional benefits of digitally optimized trials by delivering study supplies directly to participants’ homes.

Biotium Introduces New Line of Antibodies for Exosome Detection

Biotium, a leading supplier and inventor of fluorescent cellular probes for life science research, announces the release of new ExoBrite™ Antibody Conjugates

BioIVT Launches New Scientific Advisory Board

Its new Board members will provide expert insight into ADME-Tox, biomarker, assay, cell and gene therapy, and immuno-oncology advances.

Celegence adds report writing functionality to EU MDR & IVDR compliance technology CAPTIS™ to help streamline medical writing and document maintenance

Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has today announced the addition of new features to CAPTIS™ to help the device and diagnostic industry produce compliant Post Market Surveillance (PMS) documentation more efficiently.

3DR Labs Introduces New Imaging Services to Meet Specific Radiology Market Needs

Its new Cardiac Center of Excellence and Imaging Excellence Advisory Services are designed to support radiology departments nationwide.

RefleXion Announces Licensing Agreement with Mirada Medical to Advance Personalized Cancer Treatment

Rapid, adaptive radiotherapy treatment plans hold potential to reduce toxicity and improve patient outcomes

Oncology news: Capnopharm announces asset purchase of Capnomed as PIPAC™ shows superiority over IV Chemotherapy in first randomised data presented at ASCO 2022

Capnopharm GmbH today announced it has entered into an asset purchase agreement to acquire all operating assets from Capnomed GmbH.

Vaccizone selects Exothera for process development and GMP manufacturing of its SARS‑CoV‑2 vaccine based on proprietary ASC technology

Vaccizone has selected Exothera S.A. to fast-track process development of its SARS‑CoV‑2 vaccine for European clinical trials.

DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400

DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400 Being a leader in Dry Powder Inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose

CD Formulation Enlarges Particulate Matter Testing Capability

A Comprehensive Portfolio of Hydrophobic Polymers Makes Breakthroughs Closer

BOC Sciences New Promotes: Comprehensive Oligo Synthesis Service Package

BOC Sciences Fermentation CDMO Services Prompt a New Era for Pharmaceutical Compound Production

BOC Sciences Contributes to a Large Portion of PseudoUridine Production for mRNA Vaccine R&D

BOC Sciences Commitment at BIO 2022: From Concept to GMP Production

IgGenix Demonstrates Potential for Single-Cell RNA-Sequencing in Tree Nut Allergies